Current therapy of Eisenmenger syndrome. - Wikidata - wikimedia - TriplyDB

Current therapy of Eisenmenger syndrome.

Current therapy of Eisenmenger syndrome.

http://www.wikidata.org/entity/Q42344254

about

Current therapy of Eisenmenger syndrome.

http://www.wikidata.org/entity/Q42344254

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Current therapy of Eisenmenger syndrome.

@en

Current therapy of Eisenmenger syndrome.

@nl

type

label

Current therapy of Eisenmenger syndrome.

@en

Current therapy of Eisenmenger syndrome.

@nl

prefLabel

Current therapy of Eisenmenger syndrome.

@en

Current therapy of Eisenmenger syndrome.

@nl

P1433

Q42344254-6217A604-E33E-4928-8B84-2342693CF4C0

P1476

Q42344254-23BBA606-B8EC-44F6-94EC-11DD2C460A76

P2093

Q42344254-AA9A349D-8A61-48B2-97B0-795485EEA750

Q42344254-E06EB237-C7F2-4FBC-8AE0-8C5720FD67B2

P2860

Q42344254-3A269885-703D-475D-950A-4638900DB90E

Q42344254-53EBD6C4-8C11-4340-AA26-385E26632A5D

Q42344254-7BC66B23-54BB-4EED-A86F-3131593F449D

Q42344254-7FFA8734-5935-477B-B7F8-D275812E78CD

Q42344254-B381C7C9-27C7-4461-A7AA-5D1682805F9B

Q42344254-BD1D7C0A-D36C-412D-BC37-54CB0CF40146

Q42344254-C00B2660-3302-4B9E-811D-E0CC16F5283F

Q42344254-CA801450-6D0E-4F52-B719-03FF60364BDB

Q42344254-CC65D79D-FD82-44A0-B0FC-9CACDE99B5BC

Q42344254-D8529EEA-E45B-4661-95FC-153FDAA48F75

P304

Q42344254-59C485F2-761D-4BA8-9480-8F5121C8FBFA

P31

Q42344254-6820ec9d-f619-4a9e-8a16-a2313c5461f3

Q42344254-874768BF-5CD7-4C68-92DC-F1554932E205

P356

Q42344254-6DE5FFB9-BABA-4FF3-8465-14274106D5B4

P433

Q42344254-B828924F-BE51-4621-A0C0-634849C8B482

P478

Q42344254-16572E3F-917E-420C-91D0-216116805CA0

P577

Q42344254-8B991F97-0E4A-492C-BD8A-717AA51B8D16

P698

Q42344254-7AFFF7A7-A61F-4BA7-83E0-23A82456A701

P932

Q42344254-A977A9D8-3D74-4B18-ABB4-CD5739238EBD

P356

P1433

Journal of thoracic disease

P1476

Current therapy of Eisenmenger syndrome.

@en

P2093

Minsu Kim

http://www.w3.org/2001/XMLSchema#string

Wook-Jin Chung

http://www.w3.org/2001/XMLSchema#string

P2860

Current therapy and outcome of Eisenmenger syndrome: data of the German National Register for congenital heart defects

Functional class and targeted therapy are related to the survival in patients with pulmonary arterial hypertension.

Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension.

Pathologic assessment of vasculopathies in pulmonary hypertension.

Baseline Characteristics of the Korean Registry of Pulmonary Arterial Hypertension.

Treat-to-target strategies in pulmonary arterial hypertension: the importance of using multiple goals.

Five-Year outcomes of patients enrolled in the REVEAL Registry.

Effects of inhaled iloprost on exercise capacity, quality of life, and cardiac function in patients with pulmonary arterial hypertension secondary to congenital heart disease (the Eisenmenger syndrome) (from the EIGER Study).

Long-term results from the EARLY study of bosentan in WHO functional class II pulmonary arterial hypertension patients.

Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension.

P304

3009-3011

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/JTD.2016.11.27

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28066570

http://www.w3.org/2001/XMLSchema#string

P932

5179453

http://www.w3.org/2001/XMLSchema#string